Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guerin therapy

被引:6
|
作者
Numakura, Satoe [1 ]
Morikawa, Teppei [1 ]
Ushiku, Tetsuo [1 ]
Toyoshima, Toyoaki [2 ]
Fukayama, Masashi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan
[2] Yuai Mem Hosp, Dept Urol, Koga, Japan
关键词
Eosinophilic granuloma; Histiocytosis X; Immunohistochemistry; Immunotherapy; Pathological diagnosis; ERDHEIM-CHESTER DISEASE; BRAF V600E MUTATION; EOSINOPHILIC CYSTITIS; MITOMYCIN-C; CARCINOMA; VEMURAFENIB; DIAGNOSIS; GRANULOMA; MELANOMA; TUMOR;
D O I
10.1016/j.prp.2013.11.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report an extremely rare case of Langerhans cell histiocytosis (LCH) of the urinary bladder. A 68-year-old man presented with gross hematuria. Cystoscopy showed multiple papillary tumors in the urinary bladder, and transurethral resection was performed. Pathological diagnosis was high-grade papillary urothelial carcinoma with lamina propria invasion. The patient received six treatments with intravesical Bacillus Calmette-Guerin (BCG) therapy. Seven months after surgery, follow-up cystoscopy showed three elevated lesions in the urinary bladder, two of which were identified histologically as recurrent urothelial carcinoma. Microscopic examination of the lesion at the anterior wall revealed diffuse infiltration of medium to large histiocytoid cells in the lamina propria, many of which had distorted nuclei and nuclear grooves. Dense eosinophilic infiltration was also observed. Immunohistochemically, the histiocytoid cells were diffusely positive for S-100 and CD1a, but negative for cytokeratin AE1/AE3 and melanosome-associated antigen recognized by HMB-45. Based on the histological and immunohistochemical features, we diagnosed the lesion as LCH of the urinary bladder. There was no evidence of recurrence of either bladder cancer or LCH after an 18-month follow-up. To avoid misdiagnosis, urologists and pathologists should be aware that LCH may develop in the urinary bladder after intravesical BCG therapy for bladder cancer. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [21] Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guerin Instillation?
    Hong, Sungwoo
    Kim, Seong-Cheol
    Kwon, Taekmin
    Jeong, In Gab
    Kim, Choung-Soo
    Ahn, Hanjong
    Hong, Jun Hyuk
    PLOS ONE, 2014, 9 (07):
  • [22] Safe use of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer during breastfeeding: a case report
    Barbur, Erol
    Doganca, Tunkut
    Obek, Can
    IMMUNOTHERAPY, 2022, 14 (10) : 759 - 764
  • [23] Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer
    Camargo, Juliana A.
    Passos, Gabriela R.
    Ferrari, Karen L.
    Billis, Athanase
    Saad, Mario J. A.
    Reis, Leonardo O.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E587 - E593
  • [24] Determination of Bacillus Calmette-Guerin Concentration Integrated in Delivery Materials for Intravesical Infusion Therapy of Superficial Bladder Cancer
    Wu, Chengge
    Sun, Kangning
    Li, Aimin
    Sun, Xiaoning
    ENGINEERING SOLUTIONS FOR MANUFACTURING PROCESSES, PTS 1-3, 2013, 655-657 : 1917 - +
  • [25] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    UROLOGY, 2019, 124 : 120 - 125
  • [26] Thirty-Five Years of Intravesical Bacillus Calmette-Guerin for Bladder Cancer: Where Now?
    Catto, James W. F.
    EUROPEAN UROLOGY, 2011, 60 (01) : 37 - 38
  • [27] Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer
    Librenjak, D
    Situm, M
    Eterovic, D
    Dogas, Z
    Gotovac, J
    CROATIAN MEDICAL JOURNAL, 2003, 44 (02) : 187 - 192
  • [28] Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing?
    Ayres, Benjamin E.
    Griffiths, T. R. Leyshon
    Persad, Raj A.
    BJU INTERNATIONAL, 2010, 105 : 8 - 13
  • [29] Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer
    Hermans, Julian
    Jokisch, Friedrich
    Volz, Yannic
    Eismann, Lennert
    Pfitzinger, Paulo
    Ebner, Benedikt
    Weinhold, Philipp
    Schlenker, Boris
    Stief, Christian G.
    Tritschler, Stefan
    Schulz, Gerald B.
    CANCER CYTOPATHOLOGY, 2022, 130 (04) : 294 - 302
  • [30] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
    James, Christopher
    Gomez, Kayeromi
    Desai, Shalin
    Patel, Hiten D.
    Rac, Goran
    Doshi, Chirag P.
    Dornbier, Ryan
    Bajic, Petar
    Halverson, Thomas
    Gupta, Gopal N.
    Quek, Marcus L.
    Gorbonos, Alex
    Flanigan, Robert
    Wolfe, Alan J.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13